Ranibizumab: a review of its use in the treatment of neovascular age-related macular degeneration.
about
Systemic adverse events after intravitreal bevacizumab versus ranibizumab for age-related macular degeneration: a meta-analysis.Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular DegenerationThe role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration--a phase IV randomised clinical trial with ranibizumab: the FLUID study.Aflibercept in wet AMD: specific role and optimal use.Understanding the patient's lived experience of neovascular age-related macular degeneration: a qualitative study.Mechanisms of age-related macular degeneration and therapeutic opportunities.Vascular endothelial growth factor regulates primate choroid-retinal endothelial cell proliferation and tube formation through PI3K/Akt and MEK/ERK dependent signaling.The effects of ranibizumab injections on fluorescein angiographic findings and visual acuity recovery in age-related macular degeneration.EGHB010, a Standardized Extract of Paeoniae Radix and Glycyrrhizae Radix, Inhibits VEGF-Induced Tube Formation In Vitro and Retinal Vascular Leakage and Choroidal Neovascularization In Vivo.c-Jun-mediated microRNA-302d-3p induces RPE dedifferentiation by targeting p21Waf1/Cip1.Aster koraiensis Extract and Chlorogenic Acid Inhibit Retinal Angiogenesis in a Mouse Model of Oxygen-Induced Retinopathy.
P2860
Q34444212-0266900E-2095-4C09-A444-6788F20B4B7CQ34645786-930B05F5-5AAE-4484-9C8A-8EC41BCC6E69Q35968382-D5F48E6D-2E08-438E-AD74-22A045E9BC7DQ37109788-C03982F9-2848-4AA5-961C-3E45EA5717C7Q37457098-E042BA90-971F-4316-AEB7-84C868C44ED2Q38150757-67455B46-01BB-4A15-8FE5-2373508A25A9Q39142088-CFBEC845-F6F9-482E-A521-FBE0A00AA6D9Q40059605-B3A8367B-E227-47B7-9914-8205BF5E31B9Q47758215-B27624C9-4C8D-412B-A0D7-F1E9F4A81017Q52579556-1459B3C5-C523-44FB-87AD-3685FB678A1AQ55018025-B7020025-CC72-4083-8B87-59D77C79C00A
P2860
Ranibizumab: a review of its use in the treatment of neovascular age-related macular degeneration.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Ranibizumab: a review of its u ...... -related macular degeneration.
@en
type
label
Ranibizumab: a review of its u ...... -related macular degeneration.
@en
prefLabel
Ranibizumab: a review of its u ...... -related macular degeneration.
@en
P2860
P1433
P1476
Ranibizumab: a review of its u ...... -related macular degeneration.
@en
P2093
James E Frampton
P2860
P2888
P304
P356
10.1007/S40266-013-0077-9
P577
2013-05-01T00:00:00Z